Inhaled Nitric Oxide Market Report: Trends, Forecast and Competitive Analysis to 2030

Inhaled Nitric Oxide Trends and Forecast

The future of the global inhaled nitric oxide market looks promising with opportunities in the neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, and tuberculosis treatment markets. The global inhaled nitric oxide market is expected to reach an estimated $1.1 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of respiratory and other associated diseases along with ongoing research and development activities.

A more than 150-page report is developed to help in your business decisions.

Inhaled Nitric Oxide by Segment

The study includes a forecast for the global inhaled nitric oxide by product type, application, and region.

Inhaled Nitric Oxide Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Gas
• Delivery Systems

Inhaled Nitric Oxide Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Neonatal Respiratory Treatment
• Asthma and COPD
• Acute Respiratory Distress Syndrome
• Malaria Treatment
• Tuberculosis Treatment
• Others

Inhaled Nitric Oxide Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Inhaled Nitric Oxide Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies inhaled nitric oxide companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the inhaled nitric oxide companies profiled in this report include-

• Air Liquide Healthcare
• BOC Healthcare
• Matheson Tri-Gas
• Merck
• Mallinckrodt Pharmaceuticals
• Nu-Med Plus
• Perma Pure

Inhaled Nitric Oxide Market Insights

Lucintel forecasts that delivery systems is expected to witness the higher growth over the forecast period due to introduction of compact and portable delivery system, which enables for easier administration of nitric oxide therapy in various healthcare applications.

Within this market, asthma and COPD is expected to witness the highest growth due growing consumption of cigarettes, which contributes to asthma and COPD symptoms.

North America is expected to witness highest growth over the forecast period due to surging incidence of diseases like COPD and asthma, increasing aging population, and presence of major palyers in the region.

Features of the Global Inhaled Nitric Oxide Market

Market Size Estimates: Inhaled nitric oxide market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Inhaled nitric oxide market size by product type, application, and region in terms of value ($B).

Regional Analysis: Inhaled nitric oxide market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the inhaled nitric oxide market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the inhaled nitric oxide market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the inhaled nitric oxide market size?

Answer: The global inhaled nitric oxide market is expected to reach an estimated $1.1 billion by 2030.

Q2. What is the growth forecast for inhaled nitric oxide market?

Answer: The global inhaled nitric oxide market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the inhaled nitric oxide market?

Answer: The major drivers for this market are increasing prevalence of respiratory and other associated diseases along with ongoing research and development activities.

Q4. What are the major segments for inhaled nitric oxide market?

Answer: The future of the inhaled nitric oxide market looks promising with opportunities in the neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, and tuberculosis treatment markets.

Q5. Who are the key inhaled nitric oxide market companies?

Answer: Some of the key inhaled nitric oxide companies are as follows:

• Air Liquide Healthcare
• BOC Healthcare
• Matheson Tri-Gas
• Merck
• Mallinckrodt Pharmaceuticals
• Nu-Med Plus
• Perma Pure

Q6. Which inhaled nitric oxide market segment will be the largest in future?

Answer: Lucintel forecasts that delivery systems is expected to witness the higher growth over the forecast period due to introduction of compact and portable delivery system, which enables for easier administration of nitric oxide therapy in various healthcare applications.

Q7. In inhaled nitric oxide market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to surging incidence of diseases like COPD and asthma, increasing aging population, and presence of major palyers in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the inhaled nitric oxide market by product type (gas and delivery systems), application (neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, tuberculosis treatment, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?